Indo US Bio-Tech (NSE:INDOUS) EV-to-FCF: (As of Jul. 12, 2026)


NSE:INDOUS Indo US Bio-Tech Ltd NSE:INDOUS
63 GF Score
Price ₹87.52
GF Value ₹312.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Indo US Bio-Tech EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Indo US Bio-Tech's Enterprise Value is ₹2,055 Mil. Indo US Bio-Tech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil. Therefore, Indo US Bio-Tech's EV-to-FCF for today is .

The historical rank and industry rank for Indo US Bio-Tech's EV-to-FCF or its related term are showing as below:

NSE:INDOUS' s EV-to-FCF Range Over the Past 10 Years
Min: -13.71   Med: 0   Max: 0
Current: -13.71

NSE:INDOUS's EV-to-FCF is ranked worse than
100% of 136 companies
in the Agriculture industry
Industry Median: 17.06 vs NSE:INDOUS: -13.71

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-12), Indo US Bio-Tech's stock price is ₹87.52. Indo US Bio-Tech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹6.540. Therefore, Indo US Bio-Tech's PE Ratio (TTM) for today is 13.38.


Indo US Bio-Tech  (NSE:INDOUS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Indo US Bio-Tech's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=87.52/6.540
=13.38

Indo US Bio-Tech's share price for today is ₹87.52.
Indo US Bio-Tech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6.540.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Indo US Bio-Tech EV-to-FCF Related Terms


Indo US Bio-Tech EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Indo US Bio-Tech's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo US Bio-Tech EV-to-FCF Chart

Indo US Bio-Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -59.09 -173.08 -1,178.70 556.09 -15.11

Indo US Bio-Tech Quarterly Data
Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 556.09 0.00 0.00 0.00 -15.11

NSE:INDOUS vs CTVA, CF, MOS: EV-to-FCF Comparison

For the Agricultural Inputs subindustry, Indo US Bio-Tech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo US Bio-Tech EV-to-FCF vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's EV-to-FCF falls into.


NSE:INDOUS
63GF Score
Indo US Bio-Tech Ltd NSE:INDOUS
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo US Bio-Tech EV-to-FCF Calculation

Indo US Bio-Tech's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2055.175/0
=

Indo US Bio-Tech's current Enterprise Value is ₹2,055 Mil.
Indo US Bio-Tech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?

Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued. The current stock price of ₹87.52 is trading 72% below its estimated GF Value™ of ₹312.39. GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.

Key valuation signals for NSE:INDOUS:

  • EV-to-FCF:
  • GF Value™: ₹312.39 vs. price of ₹87.52 (72% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Indo US Bio-Tech Business Description

Other Exchanges 541304:India
Address Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score

Get the complete analysis for NSE:INDOUS

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹87.52
Price
₹312.39
GF Value